Home > PS Ratio > WINDLAS BIOTECH

WINDLAS BIOTECH
PS (Price/Sales) Ratio

The Current P/S Ratio of WINDLAS BIOTECH is 3.20.

Share Price ₹1,063.5Dec 11,2024
Market Cap ₹2,222.6 Cr
Sales-TTM₹695.7 CrTTM-Consolidated Results
Price/Sales3.20xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of WINDLAS BIOTECH is calculated as :

Current Market Cap [ ₹2,222.6 Cr] as on Dec 11,2024

(/) Sales [ ₹695.7 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.20x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '3.20 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !

The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.

Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH


PS Ratio Performance Analysis for WINDLAS BIOTECH

- WINDLAS BIOTECH 's latest p/e ratio is 3.20x.

- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.72x.

- WINDLAS BIOTECH 's operated at median p/e ratio of 0.92x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2024 at 1.69x.

- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
WINDLAS BIOTECH 695.73.202,222.6
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.65435,407.0
CIPLA LTD26,512.04.43117,443.0
DR REDDYS LABORATORIES LTD30,084.93.43103,338.0
ZYDUS LIFESCIENCES LTD21,483.54.6299,244.9
DIVIS LABORATORIES LTD8,614.018.28157,489.0
MANKIND PHARMA LTD11,018.09.54105,098.0
TORRENT PHARMACEUTICALS LTD11,225.010.17114,202.0
LUPIN LTD21,431.34.5898,055.1
AUROBINDO PHARMA LTD30,295.02.3571,188.9
ABBOTT INDIA LTD6,066.110.1161,336.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.35x
Max industry PS 18.28x
Median industry PS 4.62x
Average industry PS 7.22x



You may also like the below Video Courses